Monday Reads for Investors: Top 10 Essential Morning Briefs
Start your week with a proven investing ritual. This guide delivers 10 Monday reads—practical, data-driven, and ready...
Compare cost structures of Index Funds and Target Date Funds to determine which option offers lower long-term expenses for retirement savers.
25,451 articlesStart your week with a proven investing ritual. This guide delivers 10 Monday reads—practical, data-driven, and ready...
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Analysts convene Thursday to highlight key stock moves ahead of a holiday weekend, with fresh targets and cautions ac...
A single-day surge can feel like a blockbuster, but smart readers want the real story. This guide breaks down why IMA...
Wednesday brought a wave of fresh analyst calls spanning tech, industrials, and defense as traders weigh earnings and...
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
Could XRP realistically reach $100? This article breaks down the math, the regulatory headwinds, real-world use cases...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
Netflix has transformed how we watch TV, but investors are asking if the stock can reach $200. This article breaks do...
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...